Bright minds unite to improve stroke and dementia care
Innovative medical research in stroke and dementia will be outlined at a community event presented by Western Australia’s Perron Institute...
Continue reading
This website may not work correctly in Internet Explorer. We recommend switching to a more secure modern web browser such as Microsoft Edge which is already installed on your computer.
Research group
Dr. Kamal Rahimizadeh is a post-doctoral scientist in the Precision Nucleic Acid Therapeutics Group led by Associate Professor Rakesh Veedu in the Centre for Molecular Medicine and Innovative Therapeutics (CMMIT) at Murdoch University. He is focused on aptamer development and related diagnostic and therapeutic applications, including Tissue-specific Aptamers for delivering therapeutic nucleic acids and rapid diagnostic test.
Keep informed with our latest updates.
Stay up to date with our latest news and announcements.